Great ideas happen anywhere.
Finding them happens here.

Back to search results
    Date submitted
  • 29-Feb-2012

Qualiber, Inc.

Abstract

Qualiber is a nanomedicine company spun-off from UNC-Chapel Hill. It has a differentiated drug delivery platform (nanoCLIPD) that has demonstrated application for cancer and other life threatening diseases. It’s lead product (NanoGTP) has significant potential in addressing the unmet needs of pancreatic and lung cancer patients. The company is founded and led by experienced management team with successful track record developing products for patients and generating value for investors and employees.

Video

Original YouTube URL: Open

Introduction Video

Photos

Additional Questions

Who is your customer?

1) Patients with life threatening diseases such as Cancer. 2) Pharma and biotechnology companies looking to novel drug delivery solutions for their products

What problem does this idea/product solve or what market need does it serve?

Many therapeutic agents have limited clinical utility due to dose limiting toxicities. Effective formulations and delivery are key challenges facing the bio-pharmaceutical industry from small molecules to biologic based therapeutics. Qualiber has developed a novel drug delivery nanotechnology (nanoCLIPD) that has the potential to transform existing (previously FDA approved) therapeutics across multiple disease areas. Initial product development for proof of concept is focused on cancer, which continues to be a leading cause of death and suffering in the US and across the World. Though there are many chemotherapeutic agents on the market, most treatments have limited effectiveness and cause major side effects/toxicities. Qualiber's approach is to use nanoCLIPD platform to develop more effective and less toxic therapeutics, consequently providing greater clinical benefit and longer survival to patients.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

1) Successful demonstration of superior efficacy and safety of products based on nanoCLIPD delivery platform

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

The company’s founders and experienced management team have a successful track record in developing products for patients and generating value for investors.